Axitinib is a targeted therapy for advanced renal cell carcinoma (RCC). Staying informed about the latest price trends, preparation steps, and contraindications is essential for treatment planning. Below is the translated comprehensive reference:
Latest Published Prices of Axitinib
Prices vary globally based on versions, specifications, and market demand.
Generic Version
For example, Big Bear/Major Generic Brands: The specification of 5mg * 60 tablets/box has a reference price of approximately $70.
Price Fluctuations
Since prices fluctuate based on market supply and exchange rates, patients are advised to consult hospital pharmacies or authorized distributors for the most current quotes.
Preparation Before Starting Axitinib
Axitinib must be administered under professional medical supervision, requiring thorough preparation:
Baseline Medical Exams
Before starting treatment, patients must complete blood pressure monitoring, liver function tests, thyroid function evaluations, and routine urinalysis. This baseline data is crucial for tracking the treatment's impact.
Drug Interaction Assessment
Inform your doctor of all current medications, especially CYP3A4 inhibitors or inducers, as these can significantly affect drug concentration in the blood.
Lifestyle Preparation
Patients should have a home blood pressure monitor ready and learn to track readings daily. It is also recommended to prepare anti-diarrheal medication to manage common gastrointestinal side effects.
Thorough preparation improves treatment compliance and ensures early detection of adverse reactions.
Contraindications of Axitinib
Understanding when not to use Axitinib is vital for preventing severe complications.
Absolute Contraindications
Hypersensitivity to any components of Axitinib.
Untreated brain metastases.
Active gastrointestinal bleeding.
Pregnancy (due to fetal risk).
Relative Contraindications (Proceed with Caution)
Uncontrolled severe hypertension.
Moderate to severe hepatic impairment.
Patients who have recently undergone major surgery.
Patients with a history of arterial thromboembolism.
Situations Requiring Temporary Suspension
Symptoms of Reversible Posterior Leukoencephalopathy Syndrome (RPLS).
Hypertensive crisis.
Grade 3 or higher proteinuria (excess protein in urine).
During the wound-healing period after surgery.
Strictly adhering to these contraindications and suspension criteria is paramount to ensuring patient safety.
